These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7908991)

  • 1. Modulation of the function of P-glycoprotein by estramustine.
    Yang CP; Shen HJ; Horwitz SB
    J Natl Cancer Inst; 1994 May; 86(9):723-5. PubMed ID: 7908991
    [No Abstract]   [Full Text] [Related]  

  • 2. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine.
    Speicher LA; Barone LR; Chapman AE; Hudes GR; Laing N; Smith CD; Tew KD
    J Natl Cancer Inst; 1994 May; 86(9):688-94. PubMed ID: 7908988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation and multidrug resistance in response to drug treatment in the K562 human leukaemia cell line.
    Marks DC; Davey MW; Davey RA; Kidman AD
    Br J Haematol; 1993 May; 84(1):83-9. PubMed ID: 8101722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma.
    Huang CC; Wu MC; Xu GW; Li DZ; Cheng H; Tu ZX; Jiang HQ; Gu JR
    J Natl Cancer Inst; 1992 Feb; 84(4):262-4. PubMed ID: 1346405
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of P-glycoprotein activity by estramustine is limited by binding to plasma proteins.
    Smith CD; Zilfou JT; Zhang X; Hudes GR; Tew KD
    Cancer; 1995 May; 75(10):2597-604. PubMed ID: 7736407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulators of P-glycoprotein-associated multidrug resistance.
    Beck WT
    Cancer Treat Res; 1991; 57():151-70. PubMed ID: 1686715
    [No Abstract]   [Full Text] [Related]  

  • 7. Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells.
    Laing NM; Belinsky MG; Kruh GD; Bell DW; Boyd JT; Barone L; Testa JR; Tew KD
    Cancer Res; 1998 Apr; 58(7):1332-7. PubMed ID: 9537224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of cremophor EL following taxol: plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype.
    Webster L; Linsenmeyer M; Millward M; Morton C; Bishop J; Woodcock D
    J Natl Cancer Inst; 1993 Oct; 85(20):1685-90. PubMed ID: 8105099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of liposomes on P-glycoprotein function in multidrug resistant cells.
    Thierry AR; Dritschilo A; Rahman A
    Biochem Biophys Res Commun; 1992 Sep; 187(2):1098-105. PubMed ID: 1356335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for cyclosporine.
    Ryffel B; Woerly G; Rodriguez C; Foxwell BM
    J Recept Res; 1991; 11(1-4):675-86. PubMed ID: 1679456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein and tumor progression.
    Benchimol S; Ling V
    J Natl Cancer Inst; 1994 Jun; 86(11):814-6. PubMed ID: 7910218
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoblot detection of P-glycoprotein in human tumors and cell lines.
    Fredericks WJ; Chen YF; Baker RM
    Cancer Treat Res; 1991; 57():121-49. PubMed ID: 1686713
    [No Abstract]   [Full Text] [Related]  

  • 13. Liposomal delivery of antisense oligodeoxynucleotides. Application to the inhibition of the multidrug resistance in cancer cells.
    Thierry AR; Dritschilo A
    Ann N Y Acad Sci; 1992 Oct; 660():300-2. PubMed ID: 1364094
    [No Abstract]   [Full Text] [Related]  

  • 14. [Overcoming the multiple drug resistance of tumors].
    Donenko FV; Sitdikova SM; Moroz LV
    Vopr Onkol; 1991; 37(11-12):1034-41. PubMed ID: 1688278
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
    Chaudhary PM; Roninson IB
    J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer.
    Chen Y; Bieber MM; Teng NN
    Mol Carcinog; 2014 Aug; 53(8):625-34. PubMed ID: 23423781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of multidrug resistance in cancer cells.
    Wigler PW
    J Natl Cancer Inst; 1994 Jan; 86(2):148-50. PubMed ID: 7903703
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of P-glycoprotein in epithelial ovarian cancer: evaluation as a marker of multidrug resistance.
    Rubin SC; Finstad CL; Hoskins WJ; Saigo PE; Provencher DM; Federici MG; Hakes TB; Markman M; Reichman BS; Lloyd KO
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):69-73. PubMed ID: 1973872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance: molecular biology and clinical relevance.
    Rothenberg M; Ling V
    J Natl Cancer Inst; 1989 Jun; 81(12):907-10. PubMed ID: 2567355
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
    Yano S; Sone S; Nishioka Y; Naito M; Tsuruo T; Ogura T
    Jpn J Cancer Res; 1994 Feb; 85(2):194-203. PubMed ID: 7511575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.